CAPTRUST Financial Advisors
ANIK icon

CAPTRUST Financial Advisors’s Anika Therapeutics ANIK Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-646
Closed -$14K – 2153
2022
Q2 		$14K Sell
646
-37
-5% -$825 ﹤0.01% 3560
2022
Q1 		$17K Buy
683
+489
+252% +$14.9K ﹤0.01% 3473
2021
Q4 		$7K Sell
194
-4
-2% -$160 ﹤0.01% 3889
2021
Q3 		$8K Sell
198
-24
-11% -$989 ﹤0.01% 3717
2021
Q2 		$10K Sell
222
-6
-3% -$256 ﹤0.01% 3528
2021
Q1 		$9K Buy
228
+198
+660% +$7.51K ﹤0.01% 3474
2020
Q4 		$1K Buy
+30
New +$1.14K ﹤0.01% 3218

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

CAPTRUST Financial Advisors's ANIK Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Anika Therapeutics (ANIK) in Q3 2022, closing a stake of 646 shares — an estimated $14K sold.

CAPTRUST Financial Advisors first reported a position in ANIK in Q4 2020 and held it in 7 quarters. The position peaked at $17K in Q1 2022. 121 funds tracked by Wall St. Rank hold ANIK as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Anika Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 646 Anika Therapeutics shares in Q3 2022, an estimated $14K.
  • CAPTRUST Financial Advisors first reported a position in Anika Therapeutics in Q4 2020 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Anika Therapeutics position peaked at $17K in Q1 2022.
  • 121 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.